A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Tag: Pulmonary embolism

Rivaroxaban (Xarelto) and PE

Stephan Moll, MD writes… Good news: The large phase 3 clinical trial comparing 3-12 months treatment of Rivaroxaban (Xarelto) with warfarin in patients with newly diagnosed pulmonary embolism was published on 3-26-2012 in the New England Journal of Medicine [reference 1], showing that Rivaroxaban was (a) noninferior to warfarin in its efficacy, (b) caused the…

March 26, 2012
New ACCP Guidelines – DVT and PE: Highlights and Summary

Stephan Moll, MD writes… This month the American College of Chest Physicians (ACCP) published its new (2012) guidelines regarding anticoagulation and management of various thrombotic disorders, replacing the 2008 edition. The details of the new guidelines can be found here

February 27, 2012
Xarelto and DVT – Approved in Europe

Xarelto (Rivaroxaban) was approved in Europe today (Dec 19th, 2011) for patients with acute DVT. This is good news

December 19, 2011
Aspirin – Does it Prevent DVT and PE?

To some degree it does, but it is by far not as effective as warfarin or other anticoagulants. However, a very noteworthy study was presented today

December 12, 2011
VTE Prevention in Hospitalized Patients: New ACP Guideline

A new guideline was published this week about venous thromboembolism (VTE) prophylaxis in hospitalized medical sick patients and in stroke patients [link here; ref 1]. The key points of this guideline,

November 4, 2011